The Latest Breaking News on Pharma

Known cybercriminal Intelbroker claims to have breached AMD and got plenty of sensitive information that is now available for sale.

The healthcare industry is expected to witness robust growth driven by increased demand for medicines. Therefore, small-cap Wall Street healthcare favorites Amphastar Pharmaceuticals (AMPH), Catalyst Pharmaceuticals (CPRX), and Equillium (EQ) might be ideal additions to your portfolio. Keep reading….

A unanimous Supreme Court ruling means the abortion pill mifepristone remains available, including via mail delivery

Supreme Court ruling on FDA's mifepristone regulations post-Dobbs v. Jackson Women’s Health Organization overturning Roe v. Wade, emphasizing engagement in...

Supreme Court rejected conservative group’s attempt to restrict access to abortion pill medication but left the door open for further lawsuits

The biotech sector is primed for robust expansion fueled by the growing needs for personalized medicines and favorable government initiatives. Amid this backdrop, investors could consider buying biotech stocks Esperion Therapeutics (ESPR), Corcept Therapeutics (CORT), and Shionogi (SGIOY). Keep reading.

The share price recovery has been partly driven by the surge in wholesale energy prices, which is beyond his control

Urban and rural communities have come to depend on pharmacies as a trusted care option and a place for advice

French pharmacists began their first walkout in 10 years on Thursday, closing up shop over drug shortages, low regulated prices, pharmacy closures and fears medications could be sold online.

AMD expands its private bug bounty program to the general public, allowing anyone who signs up for an Intigriti account to submit bugs and get paid.

Texas has tapped more than $45 million in federal funds to get the overdose-reversing drug into the hands of law enforcement, members of the public. But the program has been plagued by supply issues, delays and lack of communication.